Legal · Accessibility

Accessibility Statement

ClearHormones is committed to ensuring digital accessibility for people with disabilities. We continuously improve user experience for everyone and apply relevant accessibility standards.

1. Conformance status

We aim to conform with the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standard, the international consensus standard developed by the W3C to make web content accessible to people with disabilities.

Current status: Partial conformance. We meet most WCAG 2.1 AA criteria; some content does not yet fully conform. We audit quarterly using axe-core 4.10 + manual screen-reader testing (VoiceOver + NVDA).

Most recent audit: 2026-06-03. Violation count across 4 audited pages: 2 (down from 87 — 97.7% reduction since baseline).

2. Accessibility features we've implemented

• Semantic HTML5 landmarks (header, nav, main, aside, footer) — labeled with aria-label when multiple of same type present
• WCAG-AA color-contrast compliance (4.5:1 for normal text, 3:1 for large text + UI components)
• Keyboard navigation support throughout — skip-to-content link, focus-visible outlines, ESC dismisses modals
• Screen reader compatibility (VoiceOver, NVDA, JAWS tested) — aria-label, aria-current, aria-live, semantic headings (h1-h6 in order)
• Alt text on all informational images (decorative images marked role="presentation")
• Resizable text up to 200% without loss of functionality
• Reduced-motion respected via prefers-reduced-motion media query
• Form labels associated with inputs; error messages programmatically announced
• Sticky in-page navigation (table of contents) for long articles
• Touch targets meet 44 × 44 px minimum (WCAG 2.5.5)

3. Known gaps

We acknowledge the following known accessibility limitations:

• Some legacy score-badge components use color-only differentiation; star-rating display added in June 2026 to provide non-color signal
• Hex-map visualization (US states grid) renders as role="group" with labeled <a> children, but screen-reader navigation could be more elegant. State table grid below the map provides alternative text-based access
• Third-party embedded content (cookie consent dialog from Klaro) — we retrofit aria-label via MutationObserver but cannot modify Klaro's internals
• A few brand-card areas with decorative dot patterns; these are aria-hidden from screen readers

We are actively addressing these — see changelog for recent fixes.

4. Assessment approach

ClearHormones assessed accessibility via:

• Automated scans: axe-core 4.10 ran quarterly across 4 representative pages (home, brand detail, cost calculator, methodology). Latest run: 2026-06-03.
• Manual keyboard testing: every interactive element reachable + operable via keyboard.
• Screen reader spot-checks: VoiceOver (macOS) + NVDA (Windows).
• Contrast verification: WebAIM Contrast Checker on all design tokens.

5. Reporting accessibility issues

If you encounter an accessibility barrier — and page or feature you cannot use because of a disability — please email us:

Accessibility contact: [email protected] — subject line: “Accessibility Issue”
Please include: the page URL, what assistive technology you use, and and description of the barrier.

We aim to acknowledge accessibility reports within 3 business days and remediate critical blocking issues within 10 business days. Lower-severity issues are queued + addressed in the next quarterly audit cycle.

6. Standards reference

Relevant standards and regulations we consult:

• WCAG 2.1 Level AA (W3C)
• Americans with Disabilities Act (ADA) — Title III website accessibility expectations
• Section 508 Refresh (US federal)
• EN 301 549 (EU) — for European users

Last updated: 2026-06-03. Related: Legal hub